ARTICLE | Company News
Aptevo regains rights to MOR209/ES414 from MorphoSys
September 8, 2017 8:40 PM UTC
Aptevo Therapeutics Inc. (NASDAQ:APVO) said it ended a 2014 deal with MorphoSys AG (Xetra:MOR; Pink:MPSYY) granting the German company worldwide rights to APVO414 (formerly MOR209/ES414). ...
BCIQ Target Profiles